May 8, 2012 – For over a year, scientists have informed of analysis results displaying that long-term use of the diabetic issues medication Actos is…
Increasing 2011 lawful activities against Takeda included a move toward class-action situations and multidistrict lawsuits. Since Aug 2011, class-action statements have been registered in the…
Many people who have developed kidney melanoma because of their therapy with Actos and other pioglitazone medicines have registered legal statements against Takeda Treatment, the…
The US Food and Treatment Management (FDA) has announced a potential security issue with Actos (pioglitazone HCL) being related to rhabdomyolysis. A potential security issue…
Issues about the protection of Actos have become the focus of an Actos whistleblower judge activity. A former Takeda Treatment consultant, Dr. Sue Ge, has…
Actos (pioglitazone hydrochloride) is a member of a type of drugs known as thiazolidinediones, which have been related to liver organ and heart issues. Actos…
Since hitting the industry in the late 90’s, doctors have recommended Actos to millions of kind 2 diabetics. Although the medication does help with diabetic…